Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-07-21
    E.g., 2018-07-21

Articles

12212 items
11:41 AM, Jun 28, 2018  |  BC Extra | Financial News

Kura, Zafgen price follow-ons

Kura Oncology Inc. (NASDAQ:KURA) and Zafgen Inc. (NASDAQ:ZFGN) each priced follow-ons of at least $60 million Thursday. Kura raised $67 million through the sale of 4 million shares at $16.75 in an offering underwritten by Leerink....
10:15 PM, Jun 27, 2018  |  BC Extra | Financial News

Tricida gains, others dip after upsized IPOs

Among three well-funded biotechs that priced IPOs, Tricida Inc. (NASDAQ:TCDA) had by far the best first-day performance Thursday, posting a 37% gain, while Translate Bio Inc. (NASDAQ:TBIO) and Forty Seven Inc. (NASDAQ:FTSV) each lost ground. All...
9:01 PM, Jun 26, 2018  |  BC Extra | Financial News

AbbVie Ventures, HealthCap lead Carisma's $53M series A

Macrophage immunotherapy company Carisma Therapeutics Inc. (Philadelphia, Pa.) raised $53 million in a series A round led by existing investors AbbVie Ventures and HealthCap. Existing investors IP Group plc (LSE:IPO), Penn Medicine and Grazia Equity,...
4:37 PM, Jun 26, 2018  |  BC Extra | Financial News

Neon raises $100M in NASDAQ IPO

Neoantigen play Neon Therapeutics Inc. (NASDAQ:NTGN) raised $100 million late Tuesday through the sale of 6.3 million shares at $16, the midpoint of its proposed range of $15-$17. The price values Neon at $451.2 million....
1:49 PM, Jun 26, 2018  |  BC Extra | Financial News

Adlai Nortye raises $50M in series B

Chinese immunotherapy company Adlai Nortye Biopharma Co. Ltd. (Hangzhou, China) raised over $50 million in a series B round led by YuanMing Capital. Matrix Partners China, DT Capital Partners and Yahui Precision Medicine Fund also...
12:46 PM, Jun 26, 2018  |  BC Extra | Financial News

Precision BioSciences raises $110M in series B

Genome editing company Precision BioSciences Inc. (Durham, N.C.) raised $110 million in an oversubscribed series B round led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital, Pontifax...
4:31 PM, Jun 25, 2018  |  BC Extra | Financial News

Frazier adds Brady as partner

Frazier Healthcare Partners hired Jim Brady as an operating partner on its growth buyout team. He was an operating partner at Marlin Equity Partners....
2:51 PM, Jun 25, 2018  |  BC Extra | Financial News

Flagship-backed Kaleido raises $101M series C round

Microbiome company Kaleido Biosciences Inc. (Bedford, Mass.) raised $101 million in a series C round. Founding investor Flagship Pioneering participated, as did several new investors including an affiliate of Abu Dhabi Investment Authority, Fidelity, Invus...
12:15 PM, Jun 25, 2018  |  BC Extra | Financial News

Dementia fund closes £250M fund, names Grant CEO

The Dementia Discovery Fund (DDF) closed its £250 million ($331.1 million) fund. The close includes a new $60 million investment from AARP. The fund also hired Angus Grant as CEO, effective July 9. Grant was corporate...
4:27 AM, Jun 25, 2018  |  BC Extra | Financial News

NASH play Akero emerges from stealth with $65M

Investors in a $65 million series A round for Akero Therapeutics Inc. (Cambridge, Mass.) believe the company's newly acquired, Phase II-ready asset could best other therapies in efficacy to treat non-alcoholic steatohepatitis. New investors Atlas Venture,...

Pages